These external labs use state of the art instrumentation and validated methods to provide accurate compound characterization
Because: patients eat less but not necessarily better and often without lifestyle restructuring The real risk We may be creating a new phenotype: Weight loss with metabolic fragility (Less overweight, but not necessarily healthier) The question is no longer: Should we prescribe GLP-1 drugs? But: What happens if patients cant stay on themand what are we not fixing underneath? Bottom line GLP-1 drugs are powerful tools
L-Carnitine L-carnitine supplements are commonly used to support energy metabolism, fat metabolism, exercise performance, recovery, and active lifestyle goals
research grant from Astellas, Bayer, Boehringer Ingelheim Japan, Fuji, Mochida, and Novartis
Caroline Geisler presented preclinical data highlighting the role of glial cells in mediating GLP-1 action in the brain